Literature DB >> 15721297

Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.

Ekaterini Pantouli1, Matthew M Boehm, Sreenivas Koka.   

Abstract

Inflammatory bone diseases are characterized by the presence of pro-inflammatory cytokines that regulate bone turnover. Osteoprotegerin (OPG) is a soluble osteoblast-derived protein that influences bone resorption by inhibiting osteoclast differentiation and activation. In the present study, we demonstrate that interleukin-1beta and tumor necrosis factor alpha induce OPG mRNA production and OPG secretion by osteoblast-like MG-63 cells. Maximum induction of OPG secretion by either cytokine requires activation of the p38 mitogen activated protein kinase (MAPK) pathway but neither the p42/p44 (ERK) nor the c-Jun N-terminal MAPK pathways. Induction of OPG mRNA by either cytokine is also p38 MAPK dependent. Taken together, these data indicate that cytokine-induced OPG gene expression and protein secretion are differentially regulated by specific MAP kinase signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721297     DOI: 10.1016/j.bbrc.2005.01.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  JNK signaling plays an important role in the effects of TNF-α and IL-1β on in vitro osteoblastic differentiation of cultured human periosteal-derived cells.

Authors:  Young-Sool Hah; Hea-Gea Kang; Hee-Young Cho; Sang-Hoon Shin; Uk-Kyu Kim; Bong-Wook Park; Sang-il Lee; Gyu-Jin Rho; Jong-Ryoul Kim; June-Ho Byun
Journal:  Mol Biol Rep       Date:  2013-05-09       Impact factor: 2.316

2.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

3.  Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner.

Authors:  Yuqiong Wu; Lunguo Xia; Yuning Zhou; Yuanjin Xu; Xinquan Jiang
Journal:  Cell Prolif       Date:  2015-04-13       Impact factor: 6.831

4.  Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas.

Authors:  Janine L Oliver; Matthew P Alexander; Allison G Norrod; Irene M Mullins; David W Mullins
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-11       Impact factor: 4.693

5.  Comparison between 8-prenylnarigenin and narigenin concerning their activities on promotion of rat bone marrow stromal cells' osteogenic differentiation in vitro.

Authors:  L G Ming; B F Ge; M G Wang; K M Chen
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

6.  Expression and regulation of osteoprotegerin in adipose tissue.

Authors:  Juan-Ji An; Dong-He Han; Dol-Mi Kim; Se-Hwa Kim; Yumie Rhee; Eun-Jig Lee; Sung-Kil Lim
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

7.  Mechanical instability and titanium particles induce similar transcriptomic changes in a rat model for periprosthetic osteolysis and aseptic loosening.

Authors:  Mehdi Amirhosseini; Göran Andersson; Per Aspenberg; Anna Fahlgren
Journal:  Bone Rep       Date:  2017-07-29

8.  Cytokines Activate JAK-STAT Signaling Pathway in MG-63 Cells on Titanium and Zirconia.

Authors:  Khaled Mukaddam; Sabrina Ruggiero; Steffen M Berger; Dietmar Cholewa; Sebastian Kühl; Daniel Vegh; Michael Payer; Michael M Bornstein; Farah Alhawasli; Elizaveta Fasler-Kan
Journal:  Materials (Basel)       Date:  2022-08-16       Impact factor: 3.748

9.  Alterations in the Synthesis of IL-1β, TNF-α, IL-6, and Their Downstream Targets RANKL and OPG by Mouse Calvarial Osteoblasts In vitro: Inhibition of Bone Resorption by Cyclic Mechanical Strain.

Authors:  Salvador García-López; Rosina Villanueva; Murray C Meikle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-28       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.